{"title":"[氯化铷治疗抑郁症的药理作用]。","authors":"A O Brundusino, S Cairoli","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the last few years antidepressant activity or Rubidium chloride has risen new interest. The drugs develops his action on dopaminergic stimulation reducing the depressive pattern. Fifteen depressed inpatients were studied for three weeks treated with Rubidium chloride (540 mg/day) and periodically monitored after hospitalization. Speed therapeutic efficacy has been shown, with lack of side effects. The results are discussed.</p>","PeriodicalId":42192,"journal":{"name":"Minerva Psichiatrica","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"1996-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The pharmacological action of rubidium chloride in depression].\",\"authors\":\"A O Brundusino, S Cairoli\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the last few years antidepressant activity or Rubidium chloride has risen new interest. The drugs develops his action on dopaminergic stimulation reducing the depressive pattern. Fifteen depressed inpatients were studied for three weeks treated with Rubidium chloride (540 mg/day) and periodically monitored after hospitalization. Speed therapeutic efficacy has been shown, with lack of side effects. The results are discussed.</p>\",\"PeriodicalId\":42192,\"journal\":{\"name\":\"Minerva Psichiatrica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"1996-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Psichiatrica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Psichiatrica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
[The pharmacological action of rubidium chloride in depression].
In the last few years antidepressant activity or Rubidium chloride has risen new interest. The drugs develops his action on dopaminergic stimulation reducing the depressive pattern. Fifteen depressed inpatients were studied for three weeks treated with Rubidium chloride (540 mg/day) and periodically monitored after hospitalization. Speed therapeutic efficacy has been shown, with lack of side effects. The results are discussed.
期刊介绍:
The journal Minerva Psichiatrica publishes scientific papers on psychiatry, psycology and psycopharmacology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.